Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials

DOI10.1158/1078-0432.CCR-16-1125WikidataQ50039167 ScholiaQ50039167MaRDI QIDQ100708FDOQ100708

Authors: Daniel H. Li, James B. Whitmore, Wentian Guo, Yuan Ji 

Publication date: 1 January 2017

Published in: Clinical Cancer Research (Search for Journal in Brave)

Cited In (1)

• Keyboard

This page was built for publication: Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q100708)